ReviewHuman vaccines & immunotherapeutics2026
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human disease.
Maya Glover et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it